Dianne Pulte1, Hermann Brenner. 1. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany. pultedi@umdnj.edu
Abstract
BACKGROUND: Therapy for head and neck cancers has evolved over the past decade, but few detailed analyses of recent developments in survival on the population level have been published. METHODS: We use period analysis and modeled period analysis to disclose recent trends in survival in patients with head and neck cancer. Data are derived from the Surveillance, Epidemiology, and End Results limited-use database. RESULTS: A major, statistically significant improvement in survival was observed, with the overall 5-year relative survival rate going from 54.7% in 1992-1996 to 65.9% in 2002-2006. Subgroup analysis showed improvement in cancers of the oral cavity, tongue, tonsils, and nasopharynx, with the greatest improvements observed in tonsillar carcinoma (+22.2 percentage points) and carcinoma of the tongue (+14.4 percentage points). Further analysis of survival for oral cavity, tonsillar, and tongue carcinoma revealed improvements in survival at each stage and across all age groups except for patients aged ≥ 75 years, with the greatest improvement occurring in locally advanced disease and in patients aged 55-64 years for carcinoma of the tongue and tonsils and those aged 15-44 years for oral cavity cancers. CONCLUSIONS: Survival has substantially improved for head and neck cancer patients over the past decade. The greatest improvement was seen in tonsillar and tongue cancers.
BACKGROUND: Therapy for head and neck cancers has evolved over the past decade, but few detailed analyses of recent developments in survival on the population level have been published. METHODS: We use period analysis and modeled period analysis to disclose recent trends in survival in patients with head and neck cancer. Data are derived from the Surveillance, Epidemiology, and End Results limited-use database. RESULTS: A major, statistically significant improvement in survival was observed, with the overall 5-year relative survival rate going from 54.7% in 1992-1996 to 65.9% in 2002-2006. Subgroup analysis showed improvement in cancers of the oral cavity, tongue, tonsils, and nasopharynx, with the greatest improvements observed in tonsillar carcinoma (+22.2 percentage points) and carcinoma of the tongue (+14.4 percentage points). Further analysis of survival for oral cavity, tonsillar, and tongue carcinoma revealed improvements in survival at each stage and across all age groups except for patients aged ≥ 75 years, with the greatest improvement occurring in locally advanced disease and in patients aged 55-64 years for carcinoma of the tongue and tonsils and those aged 15-44 years for oral cavity cancers. CONCLUSIONS: Survival has substantially improved for head and neck cancerpatients over the past decade. The greatest improvement was seen in tonsillar and tongue cancers.
Authors: G Calais; M Alfonsi; E Bardet; C Sire; T Germain; P Bergerot; B Rhein; J Tortochaux; P Oudinot; P Bertrand Journal: J Natl Cancer Inst Date: 1999-12-15 Impact factor: 13.506
Authors: Lalle Hammarstedt; David Lindquist; Hanna Dahlstrand; Mircea Romanitan; Liselotte Onelöv Dahlgren; Jeanna Joneberg; Nomi Creson; Johan Lindholm; Weimin Ye; Tina Dalianis; Eva Munck-Wikland Journal: Int J Cancer Date: 2006-12-01 Impact factor: 7.396
Authors: Katrin Hertrampf; Jörg Wiltfang; Alexander Katalinic; Olaf Timm; Hans-Jürgen Wenz Journal: J Cancer Res Clin Oncol Date: 2011-12-14 Impact factor: 4.553
Authors: Marci L Nilsen; Lingyun Lyu; Michael A Belsky; Leila J Mady; Dan P Zandberg; David A Clump; Heath D Skinner; Shyamal Das Peddada; Susan George; Jonas T Johnson Journal: Otolaryngol Head Neck Surg Date: 2019-10-15 Impact factor: 3.497
Authors: Zipei Feng; Daniel Bethmann; Matthias Kappler; Carmen Ballesteros-Merino; Alexander Eckert; R Bryan Bell; Allen Cheng; Tuan Bui; Rom Leidner; Walter J Urba; Kent Johnson; Clifford Hoyt; Carlo B Bifulco; Juergen Bukur; Claudia Wickenhauser; Barbara Seliger; Bernard A Fox Journal: JCI Insight Date: 2017-07-20
Authors: Patrick J Schuler; Malgorzata Harasymczuk; Carmen Visus; Albert Deleo; Sumita Trivedi; Yu Lei; Athanassios Argiris; William Gooding; Lisa H Butterfield; Theresa L Whiteside; Robert L Ferris Journal: Clin Cancer Res Date: 2014-02-28 Impact factor: 12.531
Authors: Namita Sinha; Matthew H Rigby; Michael L McNeil; S Mark Taylor; Jonathan Rb Trites; Robert D Hart; Martin J Bullock Journal: Mod Pathol Date: 2018-02-02 Impact factor: 7.842